Category: Alzheimer's Disease
Global Alzheimer's Disease
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Precision Psychiatry Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global precision psychiatry market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global precision ... Read More
-
Alzheimer's Drugs – A Global Market Overview
... 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Precision Psychiatry Market Report by Product Type (Products, Services), Sample (Blood-Based, Non-Blood-Based), Biomarker Type (Genetic Biomarker, Protein Biomarker), Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray, Immunoassay, Liquid Chromatography-Mass Spectrometry (LC-MS), and Others), Application (Alzheimer’s Disease, Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2024-2032
... Parkinson’s Disease, Autism, Depression, Bipolar Disease, and Others), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutions, and Others), and Region 2024-2032 The global precision psychiatry market size reached US$ 1,059.7 Million in 2023. ... Read More
-
2024 Global Forecast for Alzheimer'S Disease Drug Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Gene Therapy for CNS Disorders Market Size, Trends, Analysis, and Outlook By Indication (Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Batten Disease), By Type (Ex Vivo, In Vivo), By End-User (Hospitals, Speciality Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Gene Therapy for CNS Disorders market size is poised to register 25.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Mental Health Screening Market by Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia), Screening (Self, Interview, Observation, Biomarker), Technology (mHealth, Remote Platform, Telehealth), Age, Setting - Global Forecast to 2029
... projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues due to the growing geriatric population ... Read More
-
Drug Delivery Across Blood-Brain Barrier Market Size, Trends, Analysis, and Outlook By Drug Delivery Technology (Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing the Permeability of BBB, Passive Diffusion, Others), By Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030
... Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Drug Delivery Across Blood-Brain Barrier market size is poised to register 19.61% growth from 2024 to 2030, ... Read More
-
Active Wheelchair Market Size, Trends, Analysis, and Outlook By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030
... Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Active Wheelchair market size is poised to register 5.04% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Trends, Analysis, and Outlook By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Others), By Application (In Vitro Diagnostics Application, Research Application), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Immunoassay for Neurological Biomarkers market size is poised to register 17.33% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
The 2025-2030 World Outlook for Drugs for Alzheimer's and Parkinson's Diseases
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Disorders
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Dementia Associated with Alzheimer's Diseases
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Neurological Biomarkers for Alzheimers and Parkinsons Diseases
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Critical and Chronic Care Products
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
Research Assistance
